Suppr超能文献

症状性中度冠状动脉狭窄患者微血管阻力储备的预后意义。

Prognostic Implications of Microvascular Resistance Reserve in Symptomatic Patients With Intermediate Coronary Stenosis.

机构信息

Division of Cardiology, Department of Internal Medicine, Heart Center, Chonnam National University Hospital, Chonnam National University Medical School, Gwangju, South Korea.

Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.

出版信息

JACC Cardiovasc Interv. 2024 Mar 25;17(6):786-797. doi: 10.1016/j.jcin.2024.01.008.

Abstract

BACKGROUND

Microvascular resistance reserve (MRR) is a novel index reflecting coronary microcirculatory function, irrespective of epicardial coronary artery stenosis. There is limited evidence regarding whether MRR can be an independent prognostic tool in patients with stable ischemic heart disease (IHD).

OBJECTIVES

The aim of this study was to evaluate clinical outcomes according to MRR in patients with stable IHD accompanied with or without significant epicardial coronary artery stenosis.

METHODS

The present study included 547 consecutive patients undergoing systematic echocardiographic and invasive physiological assessment for suspected stable IHD. Significant epicardial coronary artery stenosis was defined as fractional flow reserve (FFR) ≤0.80. Coronary microvascular dysfunction (CMD) was defined as MRR ≤3.0. The primary outcome was major adverse cardiovascular events (MACE), a composite of cardiovascular death, myocardial infarction, repeat revascularization, and admission for heart failure.

RESULTS

Among the study group, 172 patients (31.4%) had FFR ≤0.80, and 200 patients (36.6%) had CMD defined by MRR ≤3.0. MRR showed no significant correlation with FFR (R = -0.031; P = 0.469), but it was significantly correlated with the index of microcirculatory resistance (R = -0.353; P < 0.001), N-terminal pro-B-type natriuretic peptide (R = -0.296; P < 0.001), left ventricular filling pressure (E/e' ratio) (R = -0.224; P < 0.001), and diastolic dysfunction grade (P < 0.001). During a median follow-up period of 3.3 years (Q1-Q3: 2.0-4.5 years), MRR was significantly associated with MACE risk (HR: 1.23 per 1-U decrease; 95% CI: 1.12-1.36; P < 0.001). CMD defined by MRR ≤3.0 was associated with an increased MACE risk for both FFR >0.80 (41.0% vs 26.0%; adjusted HR: 1.59; 95% CI: 1.07-2.35; P = 0.021) and FFR ≤0.80 (34.7% vs 14.8%; adjusted HR: 2.32; 95% CI: 1.12-4.82; P = 0.024).

CONCLUSIONS

Decreased MRR was associated with the presence of cardiac diastolic dysfunction as well as increased left ventricular filling pressure. The presence of CMD defined by MRR was independently associated with the risk for a composite of cardiovascular death, myocardial infarction, repeat revascularization, and admission for heart failure in patients with stable IHD, irrespective of significant epicardial coronary artery stenosis. (Prognostic Impact of Cardiac Diastolic Function and Coronary Microvascular Function [DIAST-CMD]; NCT05058833).

摘要

背景

微血管阻力储备(MRR)是一种反映冠状动脉微循环功能的新指标,与心外膜冠状动脉狭窄无关。关于 MRR 是否可以成为稳定型缺血性心脏病(IHD)患者的独立预后工具,目前证据有限。

目的

本研究旨在评估伴有或不伴有显著心外膜冠状动脉狭窄的稳定型 IHD 患者的 MRR 临床预后。

方法

本研究纳入了 547 例疑似稳定型 IHD 患者,这些患者接受了系统的超声心动图和有创生理评估。显著的心外膜冠状动脉狭窄定义为血流储备分数(FFR)≤0.80。冠状动脉微血管功能障碍(CMD)定义为 MRR≤3.0。主要不良心血管事件(MACE)是复合终点,包括心血管死亡、心肌梗死、再次血运重建和心力衰竭住院。

结果

在研究组中,172 例(31.4%)患者的 FFR≤0.80,200 例(36.6%)患者的 MRR≤3.0,提示存在 CMD。MRR 与 FFR 无显著相关性(R=-0.031;P=0.469),但与微血管阻力指数(R=-0.353;P<0.001)、N 末端脑钠肽前体(R=-0.296;P<0.001)、左心室充盈压(E/e' 比值)(R=-0.224;P<0.001)和舒张功能障碍分级(P<0.001)有显著相关性。在中位 3.3 年(Q1-Q3:2.0-4.5 年)的随访期间,MRR 与 MACE 风险显著相关(HR:每降低 1-U 增加 1.23;95%CI:1.12-1.36;P<0.001)。MRR 定义的 CMD(≤3.0)与 FFR>0.80(41.0%比 26.0%;调整 HR:1.59;95%CI:1.07-2.35;P=0.021)和 FFR≤0.80(34.7%比 14.8%;调整 HR:2.32;95%CI:1.12-4.82;P=0.024)患者的 MACE 风险增加相关。

结论

MRR 降低与舒张期心脏功能障碍以及左心室充盈压升高有关。MRR 定义的 CMD 与稳定型 IHD 患者的心血管死亡、心肌梗死、再次血运重建和心力衰竭住院的复合风险独立相关,无论是否存在显著的心外膜冠状动脉狭窄。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验